| Filed On | Filing |
|---|---|
| 08 Oct 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Exhibit 99.2 AI-POWERED, PORTABLE BRAIN MRI ® The Swoop Portable MR Imaging System is Driving the Future of Brain Health Corporate Investor Deck – October 2026 The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks ... |
| 18 Sep 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On September 17, 2026, Hyperfine, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the clos... |
| 25 Aug 2026 |
Form 4: Teisseyre Thomas, Chief Operating Officer
Sold 7,345 shares ($6.27K) |
| 25 Aug 2026 |
Form 4: Hale Brett, CFO and CAO
Sold 7,345 shares ($6.27K) |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 28 Jul 2026 | SCHEDULE 13G |
| 04 Jun 2026 |
Form 4: Wolterman Dan, Director
Granted 52,600 Stock Options (right to buy) |
| 27 May 2026 |
Form 4: Hale Brett, CFO and CAO
Sold 6,047 shares ($9.98K) |
| 27 May 2026 |
Form 4: Teisseyre Thomas, Chief Operating Officer
Sold 6,047 shares ($9.98K) |
| 22 May 2026 |
Form 4: Fattori Ruth A, Director
Granted 157,700 Stock Options (right to buy) |
| 22 May 2026 |
Form 4: Wolterman Dan, Director
Granted 157,700 Stock Options (right to buy) |
| 22 May 2026 |
Form 4: Dahldorf John T, Director
Granted 157,700 Stock Options (right to buy) |
| 22 May 2026 |
Form 4: Rothberg Jonathan M, Director
Granted 157,700 Stock Options (right to buy) |
| 21 May 2026 | EFFECT |
| 21 May 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 19 May 2026 | CORRESP |
| 18 May 2026 | UPLOAD |
| 12 May 2026 | S-3 |
| 12 May 2026 | 10-Q |
Loading...
